Sales momentum accelerated in Q2, thanks to the strong demand for high-margin consumables and positive growth across regions, with China being the key contributor. Given the faster deployment of vaccines, pandemic headwinds seem to be fading away and, as the demand for elective surgeries is likely to remain high, management is optimistic for FY20/21. However, increasing competition in key markets is a key risk.
10 May 2021
Momentum accelerates significantly in Q2
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Momentum accelerates significantly in Q2
Sales momentum accelerated in Q2, thanks to the strong demand for high-margin consumables and positive growth across regions, with China being the key contributor. Given the faster deployment of vaccines, pandemic headwinds seem to be fading away and, as the demand for elective surgeries is likely to remain high, management is optimistic for FY20/21. However, increasing competition in key markets is a key risk.